Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

FromThe Fellow on Call: The Heme/Onc Podcast


Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

FromThe Fellow on Call: The Heme/Onc Podcast

ratings:
Length:
20 minutes
Released:
Oct 4, 2023
Format:
Podcast episode

Description

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!Content: - Definitions for "primary refractory" vs. "relapsed" disease- How do we approach patients with primary refractory disease? - What are the treatment regimens for patients with primary refractory disease?- What is the role of CAR-T therapy? - How do we "bridge" patients to CAR-T therapy? - How do we monitor patients post CAR-T? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Oct 4, 2023
Format:
Podcast episode

Titles in the series (100)

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.